MRK - Merck & Co., Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue42,294,00040,122,00039,807,00039,498,000
Cost of Revenue13,488,00012,640,00013,502,00014,423,000
Gross Profit28,806,00027,482,00026,305,00025,075,000
Operating Expenses
Research Development9,652,0009,818,0006,921,0006,613,000
Selling General and Administrative9,555,0009,516,0009,313,0009,799,000
Non Recurring----
Others----
Total Operating Expenses32,695,00031,974,00029,736,00030,835,000
Operating Income or Loss9,599,0008,148,00010,071,0008,663,000
Income from Continuing Operations
Total Other Income/Expenses Net-898,000-1,627,000-5,412,000-3,262,000
Earnings Before Interest and Taxes9,599,0008,148,00010,071,0008,663,000
Interest Expense-772,000-754,000-693,000-672,000
Income Before Tax8,701,0006,521,0004,659,0005,401,000
Income Tax Expense2,508,0004,103,000718,000942,000
Minority Interest181,000233,000220,00091,000
Net Income From Continuing Ops6,193,0002,418,0003,941,0004,459,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income6,220,0002,394,0003,920,0004,442,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares6,220,0002,394,0003,920,0004,442,000